Log in

Relevant bibliographies by topics / Fenticonazole / Journal articles

To see the other types of publications on this topic, follow the link: Fenticonazole.

Journal articles on the topic 'Fenticonazole'

Author: Grafiati

Published: 4 June 2025

Last updated: 15 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Fenticonazole.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Persi, A., and A. Rebora. "Fenticonazole: A Clinical Trial: Fenticonazol: Ein klinischer Versuch." Mycoses 28, no. 4 (2009): 206–9. http://dx.doi.org/10.1111/j.1439-0507.1985.tb02117.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Стефано, Веральді, and Мілані Родольфо. "TOPICAL FENTICONAZOLE IN DERMATOLOGY AND GYNAECOLOGY. CURRENT ROLE IN THERAPY." REPRODUCTIVE ENDOCRINOLOGY, no. 47 (June 30, 2019): 78–82. https://doi.org/10.18370/2309-4117.2019.47.78-82.

Full text

Abstract:

The objective of this review is to present the current clinical data on the use of fenticonazole, including data on its efficacy in mixed infections, and to discuss the clinical role of fenticonazole in dermatological and gynaecological indications. Fenticonazole is an imidazole derivative with a broad spectrum of antimycotic activity against dermatophytes and yeasts in in vitro and clinical studies. Fenticonazole exerts its unique antimycotic mechanism of action in the following three ways: (I) inhibition of the secretion of protease acid by Candida albicans; (II) damage to the cytoplasmic me

APA, Harvard, Vancouver, ISO, and other styles

3

Gorle, Ashish, Pritam Jain, Pankaj Nerkar, Nitin Haswani, Saurabh Chordiya, and Saipudeen H. Kommakayam. "Quantitative estimation of fenticonazole nitrate by zero-order derivative area under curve spectrophotometric methods in bulk and in-capsule dosage form." International Journal of Pharmaceutical Chemistry and Analysis 11, no. 2 (2024): 175–79. http://dx.doi.org/10.18231/j.ijpca.2024.025.

Full text

Abstract:

The purpose of this study is to establish Zero-order UV-Spectrophotometric - absorbance and Zero Order- Area under curve (AUC) methods for estimation of Fenticonazole Nitrate in bulk and vaginal capsules. Fenticonazole Nitrate is an antifungal drug and it is completely insoluble in water. Methanol was used as solvent for solubilization of Fenticonazole Nitrate. Maximum absorption for Fenticonazole Nitrate was found to be at wavelength 253 nm when dissolved in Methanol. The methods are based upon measurement of absorbance at 253nm and integration of area under curve for analysis of Fenticonazol

APA, Harvard, Vancouver, ISO, and other styles

4

Patil, Amod S., Minakshi D. Pawara, Snehal Pardeshi, Amol R. Gaware, and Manoj V. Girase. "Development of novel HPTLC method for determination of imidazole antifungal drug fenticonazole: Exploring hydrotropy." International Journal of Pharmaceutical Chemistry and Analysis 8, no. 2 (2021): 79–83. http://dx.doi.org/10.18231/j.ijpca.2021.016.

Full text

Abstract:

A novel High-Performance Thin-Layer Chromatography (HPTLC) method was portrayed for the determination of Fenticonazole Nitrate (FTZ) in Bulk and Vaginal Capsules. The estimation of Fenticonazole Nitrate was achieved on aluminium pre-coated sheets of silica gel 60 F(10 cm × 10 cm) using mobile phase Toluene: Methanol: Triethylamine (4:1:0.5 v/v/v). Densitometry detection of Fenticonazole Nitrate was performed at 254nm. Fenticonazole nitrate demonstrated a strong correlation with a coefficient of correlation of 0.999 over the concentration range of 500 – 3000 ng/band. The Rvalue for Fenticonazol

APA, Harvard, Vancouver, ISO, and other styles

5

Altmeyer, P., S. Nolting, A. Kuhlwein, E. Colli, and M. Scatigna. "Effect of Fenticonazole Spray in Cutaneous Mycosis: A Double-Blind Clinical Trial versus Cyclopyroxolamine Spray." Journal of International Medical Research 18, no. 1 (1990): 61–67. http://dx.doi.org/10.1177/030006059001800108.

Full text

Abstract:

A double-blind clinical trial was performed to evaluate efficacy and tolerance of once-daily 2% fenticonazole compared with 1% cyclopyroxolamine spray applied for 2–4 weeks in 100 patients with cutaneous mycotic lesions. After treatment lasting 21.9 ± 6.7 or 22.5 ± 6.2 days, respectively, patients receiving fenticonazole or cyclopyroxolamine had negative microscopic findings and cultures were sterile. Comparable clinical improvement was observed in both treatment groups, with 91.8% and 89.8% of patients, respectively, receiving fenticonazole or cyclopyroxolamine being evaluated as cured or gre

APA, Harvard, Vancouver, ISO, and other styles

6

Ayushi, Shrivastava, Kumar Sahu Vineet, Singh Balvir, and Mishra Nishi. "Effect of Fenticonazole Therapy on Vaginal Candidiasis: A Comparison Versus Clotrimazole." International Journal of Current Pharmaceutical Review and Research 16, no. 07 (2024): 71–75. https://doi.org/10.5281/zenodo.13169877.

Full text

Abstract:

AbstractBackground: Vaginal candidiasis (VC) is a leading cause of abnormal vaginal discharge after bacterialvaginosis at gynecologic clinics. The most common causative organism is Candida albicans, which is one of thevaginal normal floras.Objectives: aim of this study was to compare the treatment effect of fenticonazole versus clotrimazole onvaginal candidiasis patients.Methods: A total of 100 patients clinically compatible with Vulvovaginal candidiasis, diagnosis were confirmedby laboratory examination for Candida species were enrolled. All patients were randomly divided into twogroups, grou

APA, Harvard, Vancouver, ISO, and other styles

7

Wiest, W., E. Azzollini, R. Ruffmann, and Enrico Colli. "Comparison of Single Administration with an Ovule of 600 mg Fenticonazole versus a 500 mg Clotrimazole Vaginal Pessary in the Treatment of Vaginal Candidiasis." Journal of International Medical Research 17, no. 4 (1989): 369–72. http://dx.doi.org/10.1177/030006058901700410.

Full text

Abstract:

Fenticonazole is an imidazole derivative with a broad spectrum of antimycotic activity. The therapeutic activity and tolerability of 600 mg fenticonazole versus 500 mg clotrimazole were evaluated in an investigator-blind trial in 80 patients with mycologically confirmed vaginal candidiasis. Fenticonazole was administered as an ovule and clotrimazole as a vaginal pessary, both in a single administration. Therapeutic efficacy was assessed by microbiological and clinical criteria 7 days after the start of treatment. Patients cured at the end of the trial were rechecked 4–5 weeks after the start o

APA, Harvard, Vancouver, ISO, and other styles

8

Yamamoto, Eduardo Seiji, Jéssica Adriana Jesus, Adriana Bezerra-Souza, Márcia Dalastra Laurenti, Susan Pereira Ribeiro, and Luiz Felipe Domingues Passero. "Activity of Fenticonazole, Tioconazole and Nystatin on New World Leishmania Species." Current Topics in Medicinal Chemistry 18, no. 27 (2019): 2338–46. http://dx.doi.org/10.2174/1568026619666181220114627.

Full text

Abstract:

Leishmaniasis is an infectious disease caused by protozoal parasites belonging to Leishmania genus. Different clinical outcomes can be observed depending on the parasite species and health condition of patients. It can range from single cutaneous lesion until deadly visceral form. The treatment of all forms of leishmaniasis is based on pentavalent antimonials, and in some cases, the second-line drug, amphotericin B is used. Beside the toxicity of both drugs, parasites can be resistant to antimonial in some areas of the world. This makes fundamental the characterization of new drugs with leishm

APA, Harvard, Vancouver, ISO, and other styles

9

Kokoschka, E. M., G. Niebauer, M. Mounari, and P. Monici Preti. "Treatment of Dermatomycoses with Topical Fenticonazole and Econazole/Lokalbehandlung von Dermatomykosen mit Fenticonazol und Econazol." Mycoses 29, no. 1 (2009): 45–50. http://dx.doi.org/10.1111/j.1439-0507.1986.tb03256.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Antonopoulou, Stavroula, Michel Aoun, Evangelos C. Alexopoulos, et al. "Fenticonazole Activity Measured by the Methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida Vulvovaginitis Isolates from Two European Regions and Annotations on the Prevalent Genotypes." Antimicrobial Agents and Chemotherapy 53, no. 5 (2009): 2181–84. http://dx.doi.org/10.1128/aac.01413-08.

Full text

Abstract:

ABSTRACT The activity of fenticonazole was studied against 260 West and Southeast European vulvovaginal candidiasis isolates, and low MICs were displayed. Fenticonazole was assessed by European Committee on Antimicrobial Susceptibility Testing and CLSI microdilution methods for the first time, and the results showed excellent agreement (97%) and significant interclass correlation coefficient (P < 0.0001). Also, the levels of agreement for the results for itraconazole, fluconazole, and ketoconazole were 84%, 90%, and 98% (P < 0.0001), respectively. Multilocus typing by PCR fingerprinting

APA, Harvard, Vancouver, ISO, and other styles

11

Wiest, W., and R. Ruffmann. "Short-term Treatment of Vaginal Candidiasis with Fenticonazole Ovules: a Three-dose Schedule Comparative Trial." Journal of International Medical Research 15, no. 5 (1987): 319–25. http://dx.doi.org/10.1177/030006058701500508.

Full text

Abstract:

In an unblinded, randomized parallel group trial three different therapeutic dose schedules of fenticonazole (vaginal ovules) were compared in the treatment of vaginal candidiasis. A total of 60 patients, aged 17–71 years, affected by mycologically confirmed symptomatic vaginal candidiasis were included and randomly allocated to three treatment groups: 200 mg daily, for 3 days; 600 mg in a single administration; and 1000 mg in a single administration. Therapeutic efficacy was assessed by microbiological and clinical criteria 7 days after the end of the treatment. All mycologically cured patien

APA, Harvard, Vancouver, ISO, and other styles

12

Mehul P. Bagde, Dipansu Sahu, and Lalit Chaudhary. "Preparation and Evaluation of Fenticonazole Nitrate Loaded Topical Emulgel for the Treatment of Cutaneous Candidiasis." Journal of Pharma Insights and Research 2, no. 3 (2024): 070–79. http://dx.doi.org/10.69613/csf3mv80.

Full text

Abstract:

Fenticonazole nitrate is a broad-spectrum antifungal agent possessing fungicidal, antiparasitic, and fungistatic activities. It is effective against various fungi, including Candida species, dermatophytes, and Trichomonas, which are associated with skin and vaginal infections. Emulgel systems have gained significant attention as topical drug delivery vehicles due to their ability to incorporate a wide range of therapeutic molecules, including both hydrophobic and hydrophilic drugs. The primary objective of this study was to develop an emulgel formulation of fenticonazole nitrate for the treatm

APA, Harvard, Vancouver, ISO, and other styles

13

Veraldi, Stefano, and Rodolfo Milani. "Topical Fenticonazole in Dermatology and Gynaecology." Drugs 68, no. 15 (2008): 2183–94. http://dx.doi.org/10.2165/00003495-200868150-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Tumietto, Fabio, Brunella Posteraro, and Maurizio Sanguinetti. "Looking for appropriateness in the cure of mixed vaginitis: the role of fenticonazole as an empiric treatment." Future Microbiology 14, no. 16 (2019): 1349–55. http://dx.doi.org/10.2217/fmb-2019-0189.

Full text

Abstract:

Mixed vaginitis is defined as the simultaneous presence of at least two different vaginal pathogens, both contributing to an abnormal vaginal milieu leading to signs and symptoms. Pathogen coinfection occurs frequently in women with vaginitis, and both coinfection and mixed vaginitis have relevant clinical and therapeutic implications. Fenticonazole, an imidazole derivative with a broad spectrum of antimycotic and antimicrobial activity, appears at least as effective as other topical antifungals in the treatment of vulvovaginal candidiasis and can also have a major role in the treatment of mix

APA, Harvard, Vancouver, ISO, and other styles

15

Brewster, Earl, Piero Monici Preti, Ralf Ruffmann, and John Studd. "Effect of Fenticonazole in Vaginal Candidiasis: A Double-Blind Clinical Trial versus Clotrimazole." Journal of International Medical Research 14, no. 6 (1986): 306–10. http://dx.doi.org/10.1177/030006058601400604.

Full text

Abstract:

Fenticonazole is an imidazole derivative which possesses a broad spectrum antimycotic activity, including activity against Candida albicans. Its therapeutic activity and tolerability have been evaluated, in a double-blind clinical trial versus clotrimazole, in 54 patients affected by mycologically confirmed symptomatic vaginal candidiasis. Both drugs were administered intravaginally as a cream once a day for 7 days. Assessment was by laboratory mycological investigations and symptomatic evaluation. Patients ‘cured’ at the end of the trial were re-evaluated after 4–6 weeks for possible relapses

APA, Harvard, Vancouver, ISO, and other styles

16

F.B., Mirodilova, F.Kh.Abboskhanova, and A.Tojimurodov Kh. "NEW APPROACHESTO TREATMENT OF FUNGAL INFECTIONS AT WOMEN." Research Focus 2, no. 1 (2023): 369–72. https://doi.org/10.5281/zenodo.7605927.

Full text

Abstract:

The article reflects the main problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Data on the effectiveness of the broad-spectrum antimycotic drug fenticonazole in the treatment of VVC are presented, which makes it possible to increase the effectiveness of treatment and reduce the frequency of relapses of the disease.

APA, Harvard, Vancouver, ISO, and other styles

17

Periti, P., J. Cohen, B. Giannotti, E. Periti, and L. Orlandini. "Fenticonazole as Antimicrobial Chemotherapy of Superficial Fungal Infections." Journal of Chemotherapy 11, sup3 (1999): 3–42. http://dx.doi.org/10.1080/1120009x.1999.11782275.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Zivaljevic, Biljana, Ilija Golubovic, Jelena Seratlic, et al. "Efficiency of fenticonazole for the treatment of vaginal candidiasis." Srpski arhiv za celokupno lekarstvo 140, no. 7-8 (2012): 469–74. http://dx.doi.org/10.2298/sarh1208469z.

Full text

Abstract:

Introduction. Uncomplicated vulvovaginal candidiasis appears in 75% women of reproductive age. The most frequent causes are Candida albicans (85-95%) or C. glabrata, and infrequently C. krusei, C. tropicalis, C. parapsilosis, C. pseudotropicalis, etc. Objective. The aim of the study was to investigate efficiency and safety of fenticonazole for vaginal candidiasis treatment. Methods. Therapeutic effect of a single 600 mg fenticonasole vaginal capsule was observed in 417 women, aged 16-67, in five centers in Serbia. In all women, before the treatment, vaginal candidiasis was confirmed by testing

APA, Harvard, Vancouver, ISO, and other styles

19

&NA;. "Fenticonazole and cyclopyroxolamine are equally effective in cutaneous mycoses." Inpharma Weekly &NA;, no. 738 (1990): 12. http://dx.doi.org/10.2165/00128413-199007380-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Веральді, Стефано, and Родольфо Мілані. "Topical fenticonazole in dermatology and gynaecology. current role in therapy." Reproductive Endocrinology, no. 47 (June 11, 2019): 78–82. http://dx.doi.org/10.18370/2309-4117.2019.47.78-82.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Lechuga, M. J., P. Pigatto, C. Bertulessi, E. Colli, M. Scatigna, and A. Finzi. "Evaluation of the irritation and contact-sensitizing potential of fenticonazole." European Journal of Pharmacology 183, no. 6 (1990): 2272–73. http://dx.doi.org/10.1016/0014-2999(90)93817-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Faikoglu, Gokhan, Kubra Saygisever-Faikoglu, Fatmanur Otmar Ozcan, et al. "The efficacy and safety of fenticonazole in the treatment of mixed vaginitis." Pharmacy & Pharmacology International Journal 10, no. 1 (2022): 12–20. http://dx.doi.org/10.15406/ppij.2022.10.00358.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Novelli, A., E. Periti, G. B. Massi, R. Masi, T. Mazzei, and P. Periti. "Systemic Absorption of3H-Fenticonazole After Vaginal Administration of 1 Gram in Patients." Journal of Chemotherapy 3, no. 1 (1991): 23–27. http://dx.doi.org/10.1080/1120009x.1991.11739058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bayramova, Bayramova G. R., Savicheva A. M. Savicheva, Tapilskaya N. I. Tapilskaya, Ivanets T. Yu Ivanets, Donnikov A. E. Donnikov, and Andreev A. O. Andreev. "Efficacy and safety of fenticonazole in the treatment of uncomplicated vulvovaginal candidiasis." Akusherstvo i ginekologiia 5_2023 (May 31, 2023): 124–31. http://dx.doi.org/10.18565/aig.2023.134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Cusumano, V., A. L. Costa, and M. Veronese. "Evaluation of the Antifungal Activity of Fenticonazole on Strains of Candida albicans on Cellular Lines: Untersuchung der antimyzetischen Aktivität von Fenticonazol bei Candida albicans in Zellkulturen." Mycoses 28, no. 5 (2009): 238–43. http://dx.doi.org/10.1111/j.1439-0507.1985.tb02123.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Veronese, M., D. Barzaghi, A. Bertoncini, and U. Cornelli. "Fenticonazole: A New Antifungal Imidazole Derivative In Vitro and In Vivo Antimycotic Activity." Mycoses 27, no. 4 (2009): 194–202. http://dx.doi.org/10.1111/j.1439-0507.1984.tb02020.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Jung, E. G., A. Bisco, E. Azzollini, A. Sartani, and R. Ruffmann. "Fenticonazole Cream Once Daily in Dermatomycosis, a Double-Blind Controlled Trial versus Bifonazole." Dermatology 177, no. 2 (1988): 104–8. http://dx.doi.org/10.1159/000248524.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Dobrokhotova, Dobrokhotova Yu E., Borovkova E. I. Borovkova, and Burdenko M. V. Burdenko. "Effectiveness of prolonged use of fenticonazole in patients with chronic recurrent vulvovaginal candidiasis." Akusherstvo i ginekologiia 1_2024 (January 31, 2024): 130–39. http://dx.doi.org/10.18565/aig.2023.303.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Dobrokhotova, Dobrokhotova Yu E., Borovkova E. I. Borovkova, Burdenko M. V. Burdenko, and Kovler S. E. Kovler S. "Long-term outcomes of prolonged fenticonazole therapy in patients with recurrent vulvovaginal candidiasis." Akusherstvo i ginekologiia 10_2024 (October 31, 2024): 148–57. http://dx.doi.org/10.18565/aig.2024.241.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Finzi, A., A. Fioroni, P. Monici Preti, and M. Mounari. "A Double Blind Evaluation of Fenticonazole Cream 2% and Clotrimazole Cream 1% in Dermatomycoses/Doppelblindstudie mit Fenticonazol-Creme 2%ig und Clotrimazol-Creme 1%ig bei Dermatomykosen." Mycoses 29, no. 1 (2009): 41–44. http://dx.doi.org/10.1111/j.1439-0507.1986.tb03255.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Fromtling, R. A. "Overview of medically important antifungal azole derivatives." Clinical Microbiology Reviews 1, no. 2 (1988): 187–217. http://dx.doi.org/10.1128/cmr.1.2.187.

Full text

Abstract:

Fungal infections are a major burden to the health and welfare of modern humans. They range from simply cosmetic, non-life-threatening skin infections to severe, systemic infections that may lead to significant debilitation or death. The selection of chemotherapeutic agents useful for the treatment of fungal infections is small. In this overview, a major chemical group with antifungal activity, the azole derivatives, is examined. Included are historical and state of the art information on the in vitro activity, experimental in vivo activity, mode of action, pharmacokinetics, clinical studies,

APA, Harvard, Vancouver, ISO, and other styles

32

Albanese, G., R. Di Cintio, Patrizia Giorgetti, G. Galbiati, and Marisa Ciampini. "Recurrent tinea pedis: a double blind study on the prophylactic use of fenticonazole powder*." Mycoses 35, no. 5-6 (2009): 157–59. http://dx.doi.org/10.1111/j.1439-0507.1992.tb00837.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Athow-Frost, T. A. M., K. Freeman, T. A. N. Mann, R. Marks, D. Vollum, and A. P. Warin. "Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole cream." Current Medical Research and Opinion 10, no. 2 (1986): 107–16. http://dx.doi.org/10.1185/03007998609110427.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Campos, Rafael, Samara F. Bittencourt, Julio Alejandro Rojas-Moscoso, et al. "The rabbit vagina as an in vivo model for vaginal fenticonazole permeability and toxicity." Journal of Pharmacological and Toxicological Methods 94 (November 2018): 14–18. http://dx.doi.org/10.1016/j.vascn.2018.04.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Quaglia, M. Giovanna, Enrica Donati, Elena Bossù, Nicoletta Desideri, and Francesco Campana. "Determination of fenticonazole and its impurities by capillary electrophoresis and high performance liquid chromatography." Journal of Separation Science 24, no. 5 (2001): 392–96. http://dx.doi.org/10.1002/1615-9314(20010501)24:5<392::aid-jssc392>3.0.co;2-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Исаков, С. А., та А. А. Жазылбекова. "ФЕНТИКОНАЗОЛДЫ ҚОЛДАНУДЫҢ ТИІМДІЛІГІ ТҮРЛІ ТІРЛЕРДІҢ ЕМДЕУЛЕРІНДЕ". Questions of dermatology and venereology, № 1(87) (28 березня 2024): 2024–18. http://dx.doi.org/10.61075/kncdiz-2707-3696.2024.87.1.002.

Full text

Abstract:

Разноцветный лишай – это грибковое заболевание, которое является одним из лидеров среди всех дерматологических заболеваний. Проблема распространения и лечения имеет актуальный характер на протяжении длительного времени. Несмотря на длительность существования этой проблемы, лечение до сих пор иногда остаётся достаточно сложным и неэффективным в некоторых случаях. Появляются все новые факторы, способствующие развитию и хронизации этого заболевания в урбанистических районах различных стран. Для того, чтобы решить эту проблему и ввести новый протокол лечения в практику дерматологов, было проведено

APA, Harvard, Vancouver, ISO, and other styles

37

Rosalina, Ajeng illastria, Erny Sagita, and Iskandarsyah Iskandarsyah. "Novasome: Combining Ufasome and Niosome for Excellent Vesicular Drug Delivery System." Sciences of Pharmacy 2, no. 1 (2023): 35–49. http://dx.doi.org/10.58920/sciphar02010035.

Full text

Abstract:

Novasome technology is a novel encapsulation-based drug delivery method that is more effective and efficient than standard liposome systems. It is composed of a mixture of surfactant, cholesterol, and free fatty acids, which produce superior vesicle characteristics for drug delivery. Various studies have investigated the optimal combination of surfactant type, free fatty acid type, and their ratio, as well as the formulation factors that can significantly affect the vesicle characteristics. The novasome technology has demonstrated its potential for delivering a range of substances, including t

APA, Harvard, Vancouver, ISO, and other styles

38

Palacín, C., C. Tarragó, J. Agut, and A. Guglietta. "In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against vaginal yeast isolates." Methods and Findings in Experimental and Clinical Pharmacology 23, no. 2 (2001): 61. http://dx.doi.org/10.1358/mf.2001.23.2.627926.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Quaglia, M. G., E. Donati, N. Desideri, S. Fanali, F. D. D'auria, and M. Tecca. "Chiral discrimination by HPLC and CE and antifungal activity of racemic fenticonazole and its enantiomers." Chirality 14, no. 5 (2002): 449–54. http://dx.doi.org/10.1002/chir.10112.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Mehul, P. Bagde, Dipansu Sahu Dr, and Chaudhary Lalit. "Preparation and Evaluation of Fenticonazole Nitrate Loaded Topical Emulgel for the Treatment of Cutaneous Candidiasis." Journal of Pharma Insights and Research 2, no. 3 (2024): 070–79. https://doi.org/10.5281/zenodo.11490815.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Т., Ф. Татарчук, and В. Калугина Л. "Anti-recurrent therapy of chronic VVC: realities and perspectives." REPRODUCTIVE ENDOCRINOLOGY, no. 33 (February 24, 2017): 48–55. https://doi.org/10.18370/2309-4117.2017.33.48-55.

Full text

Abstract:

Chronic recurrent vulvovaginal candidiasis (VVC) occurs in 50% of women of childbearing age, while 20–50% of women in the normal microflora of the vagina determine fungi of the genus Candida without manifestation of clinical symptoms. To date, the search for schemes of VVC anti-recurrent therapy was carried out mainly in the aspect of the use of oral anti-mycotics. However, taking into account their potential toxicity and drug load on patients at the groups of risk, the authors of the article note that it is most expedient to use local preparations. The article presents the results of lo

APA, Harvard, Vancouver, ISO, and other styles

42

Mao, Weixing, Yiya Wang, Wenhui Hu, Feifei Jiao, Hongwei Fan, and Li Ding. "Determination of fenticonazole in human plasma by HPLC–MS/MS and its application to pharmacokinetic studies." Journal of Pharmaceutical Analysis 7, no. 1 (2017): 63–70. http://dx.doi.org/10.1016/j.jpha.2016.09.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Lawrence, A. G., E. T. Houang, E. Hiscock, M. B. Wells, E. Colli, and M. Scatigna. "Single Dose Therapy of Vaginal Candidiasis: A Comparative Trial of Fenticonazole Vaginal Ovules Versus Clotrimazole Vaginal Tablets." Current Medical Research and Opinion 12, no. 2 (1990): 114–20. http://dx.doi.org/10.1185/03007999009110479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Leiste, D., W. Braun, W. Fegeler, et al. "A double-blind clinical trial of fenticonazole (2%) spray versus naftifine (1%) spray in patients with cutaneous mycoses." Current Medical Research and Opinion 11, no. 9 (1989): 567–75. http://dx.doi.org/10.1185/03007998909112673.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Feng, Zhenbin, Qiaogen Zou, Xiaoheng Tan, Wenjun Che, and Zunjian Zhang. "Determination of fenticonazole enantiomers by LC-ESI-MS/MS and its application to pharmacokinetic studies in female rats." Arzneimittelforschung 61, no. 10 (2012): 587–93. http://dx.doi.org/10.1055/s-0031-1300557.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Vannini, P., E. M. Difonzo, C. I. Cordaro, A. Sartani, and E. Panconesi. "New Therapeutic Approach in Skin Mycoses: A Comparative Trial Once Versus Twice Daily Applications of Fenticonazole in Comparison to Miconazole/Neuer Therapieansatz bei Hautmykosen: Studie über die tägliche Einmal- und Zweimal-anwendung von Fenticonazol i." Mycoses 31, no. 5 (2009): 280–84. http://dx.doi.org/10.1111/j.1439-0507.1988.tb03987.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Cipolletti, Manuela, Stefania Bartoloni, Claudia Busonero, Martina Parente, Stefano Leone та Filippo Acconcia. "A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells". International Journal of Molecular Sciences 22, № 6 (2021): 2915. http://dx.doi.org/10.3390/ijms22062915.

Full text

Abstract:

17β-estradiol (E2) exerts its physiological effects through the estrogen receptor α (i.e., ERα). The E2:ERα signaling allows the regulation of cell proliferation. Indeed, E2 sustains the progression of ERα positive (ERα+) breast cancers (BCs). The presence of ERα at the BC diagnosis drives their therapeutic treatment with the endocrine therapy (ET), which restrains BC progression. Nonetheless, many patients develop metastatic BCs (MBC) for which a treatment is not available. Consequently, the actual challenge is to complement the drugs available to fight ERα+ primary and MBC. Here we exploited

APA, Harvard, Vancouver, ISO, and other styles

48

Albash, Rofida, Carol Yousry, Abdulaziz Mohsen Al-Mahallawi, and Ahmed Adel Alaa-Eldin. "Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: in-vitro characterization, statistical optimization, and in-vivo assessment." Drug Delivery 28, no. 1 (2020): 1–9. http://dx.doi.org/10.1080/10717544.2020.1859000.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Fernández-alba, J., A. Valle-Gay, M. Dibildox, et al. "Fenticonazole Nitrate for Treatment of Vulvovaginitis: Efficacy, Safety, and Tolerability of 1-Gram Ovules, Administered as Ultra-Short 2-Day Regimen." Journal of Chemotherapy 16, no. 2 (2004): 179–86. http://dx.doi.org/10.1179/joc.2004.16.2.179.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Costa, A. L., A. Valenti, and M. Veronese. "Study of the Morphofunctional Alterations Produced by Fenticonazole on Strains of Candida albicans, using the Scanning Electron Microscope (S. E. M.)." Mycoses 27, no. 1 (2009): 29–35. http://dx.doi.org/10.1111/j.1439-0507.1984.tb01979.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!